Injective (INJ) Surges 5.45% on Nasdaq Staked ETF Filing

Injective (INJ) rose 5.45% in 24 hours, likely due to a Nasdaq filing for a Staked INJ ETF. The ETF, if approved, would stake most of its INJ holdings and could reduce supply. The Injective Foundation plans to invest up to $15 million in the ETF, paid in INJ. The broader crypto market remained flat during this period.

Original reporting
Published Oct 31, 2026, 4:06 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 31, 2026, 9:12 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Injective (INJ) Surges 5.45% on Nasdaq Staked ETF Filing — source image
Decision brief

The 30-second read

$INJ-USDBullishMed
01

Why it matters

The ETF filing provides a concrete supply‑side narrative that can attract institutional capital, likely sustaining short‑term bullish momentum.

02

Market read

First‑report of a Nasdaq‑listed staking ETF for INJ creates a unique catalyst, making the article highly relevant for traders focused on crypto assets.

03

What to watch

Regulatory approval risk and potential dilution of token supply if the ETF stakes a large share of INJ.

Relevance 7/10Novelty 8/10Timing: today

Background

Injective Protocol (INJ) saw a 5.45% rise over 26 hours, outpacing flat crypto markets. The surge aligns with a newly reported Nasdaq‑listed Staked INJ ETF filing and a planned $15M token purchase by the Injective Foundation.

Company-level read

Ticker impact

$INJ-USDBullishHigh confidence
Context

ETF filing update introduces a Nasdaq-listed Staked INJ ETF and a $15M foundation purchase commitment, driving a 5.45% price surge.

Expected impact

upward pressure as traders price in potential supply sink and institutional interest

Evidence & confidence

The filing is a fresh, concrete development that directly ties to the token's recent price move; no comparable news exists for other altcoins.

Market effects

Highlights growing institutional interest in staking‑based crypto ETFs, may spur similar filings for other altcoins.

Primarily affects the global crypto market; limited impact on regional equity markets.

Adds to broader narrative of crypto ETF expansion, modestly bullish for the overall crypto sector.

Counterpoint

If the ETF fails to launch or the foundation's commitment stalls, the price rally could reverse quickly.

Key entities

  • Injective Foundation

    Entity planning to purchase up to $15M in ETF shares, paid in INJ.

  • Canary Capital

    Sponsor of the proposed Staked INJ ETF filing.

Related articles

$INJ-USDHigh

Injective (INJ) Surges 11% on USDC Migration and AI Market

Injective (INJ) surged 11% in 24 hours, driven by USDC migration and AI market developments. Over $80M in USDC is set to migrate to Injective, with dYdX voting on a proposal to switch USDC backing. Injective also launched a pre-IPO market for Anthropic, reinforcing its position in RWA and AI-adjacent trading. Technical indicators and social signals support the price increase.

$INJ-USDHigh

Injective (INJ) Surges 3.18% on ETF Launch and Milestones

Injective (INJ) rose 3.18% over 41 hours, driven by the launch of the Canary Staked INJ ETF (INJC) on Nasdaq and institutional milestones. The ETF, focused on holding and staking INJ, created new demand. Additional factors include Nasdaq approval, an SEC-registered transfer agent, and institutional access, boosting INJ's institutional credibility. The price surge was tempered by modest profit-taking as traders assessed ETF seeding mechanics.

Low

Injective Surges 3.25% on Solana Launch, Regulatory Clarity

Injective (INJ) rose 3.25% in 27 hours due to its launch on Solana, regulatory clarity from the SEC, and institutional signals. The token's integration into major Solana platforms and reduced legal risks boosted its appeal. Strong on-chain activity and a positive altcoin market also supported the price increase.

Med

Injective (INJ) Surges 10.47% Amid Multiple Catalysts

Injective (INJ) surged 10.47% in 24 hours, driven by integration with Solana, new liquidity venues, and upcoming upgrades. INJ is now tradable on Raydium and supported by Phantom wallet. Circle's USDC migration and ETF filings also contributed to the rally. INJ's volume increased 50.61%, outperforming a flat crypto market.

High

Injective (INJ) Surges 17-18% on Solana Launch and ETF Progress

Injective (INJ) surged 17-18% in 24 hours due to its native launch on Solana and progress on a US-listed ETF. The token is now live on Solana with integrations across major DeFi platforms. The ETF, targeting a Nasdaq listing under 'TINJ,' aims to stake 40-60% of its INJ holdings. Trading volume spiked 181% to $226.6 million.